G. Bessard

发表

Increased lipid peroxidation in patients with pulmonary hypertension.

J. Cracowski, C. Cracowski, G. Bessard, 2001, American journal of respiratory and critical care medicine.

Therapeutic monitoring of nalbuphine: transplacental transfer and estimated pharmacokinetics in the neonate

P. Devillier, G. Bessard, E. Nicolle, 1996, European Journal of Clinical Pharmacology.

Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified?

Kalden, D. Jewell, P. Lipsky, 2006 .

Functional assessment of rat aorta after cold storage in different media

P. Devillier, J. Cracowski, G. Bessard, 1999, Fundamental & clinical pharmacology.

Vasoconstrictor effects of iso-prostaglandin F2α type-III (8-iso-prostaglandin F2α) on human saphenous veins

P. Devillier, J. Cracowski, G. Bessard, 2000 .

Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.

P. Devillier, J. Cracowski, O. Chavanon, 1999, Canadian journal of physiology and pharmacology.

Modified method of nalbuphine determination in plasma: validation and application to pharmacokinetics of the rectal route.

G. Bessard, E. Nicolle, S. Veitl, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Effects of modafinil on heat thermoregulatory responses in humans at rest.

G. Bessard, C. Raphel, J. Launay, 2002, Canadian journal of physiology and pharmacology.

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2002, Arthritis and rheumatism.

Urinary leukotriene E4 excretion: A biomarker of inflammatory bowel disease activity

B. Bonaz, G. Bessard, F. Stanke-Labesque, 2008, Inflammatory bowel diseases.

Inhibitory effects of large Ca2+-activated K+-channel blockers on β-adrenergic- and NO-donor-mediated relaxations of human and guinea-pig airway smooth muscles

P. Devillier, G. Bessard, E. Naline, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.

J. Cracowski, G. Bessard, T. Durand, 2002, Trends in pharmacological sciences.

Formation of Isoprostanes in Children with Type IIa Hypercholesterolemia

J. Cracowski, J. Mallion, J. Baguet, 2001, Journal of cardiovascular pharmacology.

Increased urinary F2-isoprostanes in patients with Crohn's disease

B. Bonaz, J. Cracowski, G. Bessard, 2002, American Journal of Gastroenterology.

5-lipoxygenase expression and activity in aorta from streptozotocin-induced diabetic rats.

G. Bessard, F. Stanke-Labesque, M. Péoc'h, 2005, Prostaglandins & other lipid mediators.

Cysteinyl Leukotrienes Modulate Angiotensin II Constrictor Effects on Aortas From Streptozotocin-Induced Diabetic Rats

P. Devillier, G. Bessard, F. Stanke-Labesque, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Characterization of the production of acetaldehyde by astrocytes in culture after ethanol exposure.

R. Saxod, G. Bessard, B. Gonthier, 1997, Alcoholism, clinical and experimental research.

Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay.

J. Cracowski, G. Bessard, J. Bessard, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Vascular Biology of the Isoprostanes

P. Devillier, J. Cracowski, G. Bessard, 2001, Journal of Vascular Research.

Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein.

P. Devillier, J. Cracowski, O. Chavanon, 2000, Journal of cardiovascular pharmacology.

Are isoprostanes a clinical marker for antioxidant drug investigation?

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2000, Fundamental & clinical pharmacology.

Increased formation of F2-isoprostanes in patients with severe heart failure

J. Cracowski, J. Baguet, F. Tremel, 2000, Heart.

Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometry.

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2005, Prostaglandins & other lipid mediators.

Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement.

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2005, Free radical biology & medicine.

Increased urinary F2-isoprostanes in patients with Crohn's disease.

B. Bonaz, J. Cracowski, G. Bessard, 2002 .

Urinary F2‐isoprostanes formation in kidney transplantation

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2001, Clinical transplantation.

Human internal mammary artery contraction by isoprostaglandin F2α type-III (8-iso-prostaglandin F2α)

P. Devillier, J. Cracowski, O. Chavanon, 2000 .

Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats

G. Bessard, F. Stanke-Labesque, F. Caron, 2006, Journal of hypertension.

Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.

P. Devillier, J. Cracowski, O. Chavanon, 2000, Cardiovascular research.

Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detection.

G. Bessard, P. Fontanille, N. Jourdil, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Involvement of cysteinyl leukotrienes in angiotensin II-induced contraction in isolated aortas from transgenic (mRen-2)27 rats

P. Devillier, J. Cracowski, G. Bessard, 2002, Journal of hypertension.

Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats.

P. Devillier, J. Cracowski, G. Bessard, 2001, Cardiovascular research.

Functional Comparison of the Antagonistic Properties of Some Angiotensin II Type 1 Receptor Blockers on the Contraction Elicited by Angiotensin II and Thromboxane A2 on Human Saphenous Veins

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2003, Journal of cardiovascular pharmacology.

Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.

P. Devillier, O. Chavanon, G. Bessard, 1999, Journal of cardiovascular pharmacology.

Inhibition of leukotriene synthesis with MK‐886 prevents a rise in blood pressure and reduces noradrenaline‐evoked contraction in L‐NAME‐treated rats

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2003, British journal of pharmacology.

Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders.

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2001, Arthritis and rheumatism.

Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle.

P. Devillier, O. Chavanon, G. Bessard, 2002, British journal of clinical pharmacology.

Reactivity of the human internal mammary artery and the gastroepiploic artery to constrictor substances

P. Devillier, J. Cracowski, O. Chavanon, 1999, The International journal of angiology : official publication of the International College of Angiology, Inc.

[A new case of myocarditis following smallpox vaccination].

G. Bessard, P. Rambaud, A. Marchal, 1974, Pediatrie.

Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2005, Canadian journal of physiology and pharmacology.

15‐F2t‐ISOPROSTANE and 5‐F2t‐ISOPROSTANE ARE NOT TRIGGERS OF MYOCARDIAL PRECONDITIONING

J. Cracowski, G. Bessard, T. Durand, 2005, Clinical and experimental pharmacology & physiology.

Response of Rat Thoracic Aorta to F2-Isoprostane Metabolites

P. Devillier, J. Cracowski, G. Bessard, 2002, Journal of cardiovascular pharmacology.

Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.

P. Devillier, G. Bessard, F. Caron, 2001, European journal of pharmacology.

Physiological variations of isoprostanes: a step forward?

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2002, Arteriosclerosis, thrombosis, and vascular biology.

The 5‐series F2‐isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein

J. Cracowski, O. Chavanon, G. Bessard, 2002 .

Automated solid-phase extraction and liquid chromatography-electrospray ionization-mass spectrometry for the determination of flunitrazepam and its metabolites in human urine and plasma samples.

G. Bessard, J. Bessard, N. Jourdil, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products.

G. Bessard, F. Stanke-Labesque, M. Mallaret, 2004, Cardiovascular research.

Vasorelaxant actions of enoximone, dobutamine, and the combination on human arterial coronary bypass grafts.

P. Devillier, J. Cracowski, O. Chavanon, 1999, Journal of cardiovascular pharmacology.

Drug interaction between infliximab and azathioprine in patients with Crohn's disease

B. Bonaz, G. Bessard, X. Roblin, 2003, Alimentary pharmacology & therapeutics.

6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine

B. Bonaz, G. Bessard, X. Roblin, 2005, Alimentary pharmacology & therapeutics.

Functional assessment of human femoral arteries after cryopreservation.

P. Devillier, J. Cracowski, G. Bessard, 1998, Journal of vascular surgery.

Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C

G. Bessard, F. Stanke-Labesque, S. Larrat, 2003, Antimicrobial Agents and Chemotherapy.

Ribavirin Quantiﬁcation in Combination Treatment of Chronic Hepatitis C

G. Bessard, F. Stanke-Labesque, S. Larrat, 2002 .

New calcium antagonists: synthesis, X-ray analysis, and smooth muscle relaxing effect of 3-[O-(benzyl-substituted)-oximino-ethers]-hexahydroazepin-2,3- diones.

P. Devillier, G. Bessard, D. Tranqui, 1999, Bioorganic & medicinal chemistry.

Comparison between the reactivities of fresh, preserved at 4°C and cryopreserved abdominal aortae of the rabbit

G. Bessard, D. Riebel, J. Mazuer, 1998 .

Thromboxane A2 and related prostaglandins in airways

P. Devillier, G. Bessard, 1997, Fundamental & clinical pharmacology.

The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein.

J. Cracowski, O. Chavanon, G. Bessard, 2002, British journal of pharmacology.

[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].

J. Cracowski, G. Bessard, F. Stanke-Labesque, 2000, La Revue de medecine interne.

Mass spectrometric determination of acromelic acid A from a new poisonous mushroom: Clitocybe amoenolens.

G. Bessard, J. Bessard, P. Saviuc, 2004, Journal of chromatography. A.

GENISTEIN AND FLUORINATED ANALOGS SUPPRESS AGONIST-INDUCED AIRWAY SMOOTH MUSCLE CONTRACTION

P. Devillier, G. Bessard, F. Bois, 1997 .

Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection.

G. Bessard, J. Bessard, N. Jourdil, 1996, Journal of chromatography. B, Biomedical applications.

Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry.

G. Bessard, J. Bessard, M. Mallaret, 1999, Journal of analytical toxicology.

Thromboxane A2 modulates cyclic AMP relaxation and production in human internal mammary artery

P. Devillier, J. Cracowski, O. Chavanon, 2000 .

Pharmacokinetics of intrarectal nalbuphine in children undergoing general anaesthesia

P. Devillier, G. Bessard, E. Nicolle, 1997, Fundamental & clinical pharmacology.

Rapid and sensitive high-performance liquid chromatographic assay for nalbuphine in plasma.

G. Bessard, E. Nicolle, F. Serre-Debeauvais, 1995, Journal of chromatography. B, Biomedical applications.

Comment on a Retraction

B. Bonaz, G. Bessard, J. Zarski, 2009, The American Journal of Gastroenterology.

[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].

G. Bessard, F. Stanke-Labesque, G. Hardy, 2004, Therapie.

[Risk of deafness following ototopical administration of aminoglycoside antibiotic (author's transl)].

G. Bessard, G. Dumas, M. Gavend, 1980, Therapie.

Cyclosporine A and cremophor EL induce contractions of human saphenous vein: involvement of thromboxane A2 receptor-dependent pathway.

P. Devillier, G. Bessard, F. Stanke-Labesque, 2000, Journal of cardiovascular pharmacology.

Monday, 9 July: Sessions

G. Bessard, F. Stanke-Labesque, M. Pérault-Pochat, 2001 .

Chronic intermittent hypoxia increases infarction in the isolated rat heart.

P. Lévy, G. Bessard, F. Stanke-Labesque, 2005, Journal of applied physiology.

Gas chromatographic quantitation of dextropropoxyphene and norpropoxyphene in urine after solid-phase extraction.

G. Bessard, J. Bessard, H. Eysseric, 1996, Journal of analytical toxicology.

Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.

P. Devillier, J. Cracowski, O. Chavanon, 1998, European journal of pharmacology.

Simultaneous determination of trimipramine and desmethyl- and hydroxytrimipramine in plasma and red blood cells by capillary gas chromatography with nitrogen-selective detection.

G. Bessard, C. Marka, N. Jourdil, 1993, Journal of chromatography.

Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report

G. Bessard, F. Stanke-Labesque, F. Bayle, 2004, European Journal of Clinical Pharmacology.

Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat

P. Lévy, G. Bessard, F. Stanke-Labesque, 2006, Respiratory Physiology & Neurobiology.

[Experimental study of interactions exerted by imipramine on respiratory depression and hypotension induced by morphine derivatives].

G. Bessard, M. Gavend, M. Gavend, 1974, The´rapie (Paris).

[Hematotoxicity caused by azathioprine genetically determined and aggravated by xanthine oxidase deficiency in a patient following renal transplantation].

Y. Bechtel, G. Bessard, P. Vialtel, 1995, Presse medicale.

Zopiclone and Zolpidem Quantification in Human Plasma by High Performance Liquid Chromatography with Photo-Diode-Array Detection

G. Bessard, N. Jourdil, F. Stanke, 1996 .

There is not simple method to maintain a constant ethanol concentration in long-term cell culture: keys to a solution applied to the survey of astrocytic ethanol absorption.

R. Saxod, G. Bessard, B. Gonthier, 1997, Alcohol.

Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary artery.

P. Devillier, J. Cracowski, O. Chavanon, 2000, European journal of pharmacology.

Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseases.

J. Cracowski, G. Bessard, S. Marlière, 2002, Journal of the American College of Cardiology.

[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].

M. Loriot, P. Beaune, P. Marquet, 2007, Annales pharmaceutiques francaises.

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

M. Roustit, J. Baguet, P. Lévy, 2008, European Respiratory Journal.

Lipid Peroxidation Is Not Increased in Patients With Untreated Mild-to-Moderate Hypertension

J. Cracowski, J. Mallion, G. Bessard, 2003, Hypertension.

Oxidative stress and baroreflex sensitivity in healthy subjects and patients with mild-to-moderate hypertension

J. Cracowski, J. Mallion, J. Baguet, 2004, Journal of Human Hypertension.

[Jaundice by interaction of troleandomycin and contraceptive pills (author's transl)].

G. Bessard, J. Mingat, R. Rollux, 1979, La Nouvelle presse medicale.

[Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].

G. Bessard, J. Lecoeur, A. Franco, 1978, La Nouvelle presse medicale.

Urinary leukotriene E4 excretion: A biomarker of inflammatory bowel disease activity

B. Bonaz, G. Bessard, F. Stanke-Labesque, 2008, Inflammatory bowel diseases.

termination of obstructive apneas Peripheral vascular resistance increases after

J. Dempsey, S. Vandi, C. Berteotti, 2015 .